No Data
No Data
Vir Biotechnology, Once a Hot Covid Stock, Finds New Path Forward in Cancer -- Barrons.com
Wednesday Market Falls, Quantum Computing Pulls Back Hard on Treasury Yield Crunch | Live Stock
Pfizer Is Maintained at Neutral by UBS
Pfizer Analyst Ratings
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
UBS Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $29